About this trial
The primary goal of this study is to estimate the effectiveness of a medical decision support system based on artificial intelligence in the endoscopic diagnosis of benign tumors.
Researchers will compare Adenoma detection rate between "artificial intelligence - assisted colonoscopy" and "conventional colonoscopy" groups to evaluate the clinical effectiveness of artificial intelligence model.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Screening coloscopy is needed
Disqualifiers
Indications for colonoscopy
Previously detected colorectal neoplasms
Previously performed colorectal surgery
Colorectal cancer
Trial design
Parallel
Treatments tested in this trial
The system based on real - time artificial intelligence - assisted for colonoscopy
DeviceRussian medical decision support system based on artificial intelligence "ArtInCol"
Treatment groups
Trial outcomes
Primary outcomes
Adenoma detection rate
In each group, the percentage of patients with at least one histologically proven adenoma or carcinoma
Secondary outcomes
Polyps detection rate
In each group, the number of patients with all type of neoplasms (polyps) was detected as a percentage of the total number of patients.
Number of polyps
In each group, the number of detected all type of polyps
Number of adenomas
In each group, the number of detected adenomas
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: